Moreover, the pretreatment with stattic reduced the IFN-γ-induced upregulation of PD-L1 on the patient-derived CD11b+ AML or MDS blasts (Fig. 4f,g, and Supplementary Fig. 12). The gene discussed is CD274; the disease is myelodysplastic syndrome.